Getting Tested With DecisionDx®-UM

The DecisionDx-UM testing process is straightforward. The DecisionDx-UM test measures the activity of 15 genes from your eye tumor. The eye tumor specimen that is tested is typically taken as a biopsy during your radiation treatment or, for those patients needing an enucleation, at the time of enucleation or afterward. Once completed, test results are sent directly to your healthcare provider and will be interpreted based on your individual situation along with other information and procedures.

Step 1

Test is

Step 2

Specimen Collected from Lab

Step 3


Step 4

Discuss Results with Your Healthcare Provider

Insurance Coverage

Castle Biosciences works with all insurance providers, including Medicare, Medicaid, commercial insurers, and the VA, to secure coverage and payment for the DecisionDx-UM test. Castle will submit insurance claims and manage the insurance billing process on behalf of patients. The company also sponsors an industry-leading Patient Assistance Program with the belief that quality care should not depend on financial considerations.

You can get more information about insurance coverage, claims processing, and financial assistance by calling 866-788-9007 and selecting option #3.

Learn How DecisionDx®-UM
Can Help Determine
Your Personalized Risk


Timing Is Critical – Talk With Your Doctor

Our Discussion Guide Will Help Determine If DecisionDx-UM Is Right for You

Hear From Other Patients

Learn How DecisionDx-UM Has Made a Significant Impact on the Lives of Other Uveal Melanoma Patients.


What’s Next?

Understanding the Results

How Do You Get a
DecisionDx-UM Test?